[1] Henley SJ，Weir HK，Jim MA，et al. Gallbladder cancer incidence and mortality，United States 1999-2011. Cancer Epidemiol Biomarkers Prev，2015，24（9）:1319-1326. [2] Ma N，Cheng H，Qin B，et al. Adjuvant therapy in the treatment of gallbladder cancer:a Meta-analysis. BMC Cancer，2015，15（3）:615-621. [3] Kuzumi H，Okabe S，Noda H，et al. Diagnosis and treatment of gallbladder cancer. Nihon Shokakibyo Gakkai Zasshi，2015，112（3）:474-493. [4] Kawakami H，Kuwatani M，Sakamoto N. Multidisciplinary treatment of gallbladder cancer-biliary and duodenal stenting. Nihon Rinsho，2015，73（3）:595-600. [5] Katayose Y，Hayashi H，Unno M. Treatment strategy of the gallbladder cancer. Nihon Rinsho，2015，73（Suppl 2）:572-575. [6] Hong H，He C，Zhu S，et al. CCR7 mediates the TNF-alpha-induced lymphatic metastasis of gallbladder cancer through the “ERK1/2-AP-1” and “JNK-AP-1” pathways. J Exp Clin Cancer Res，2016，35（1）:51-58. [7] Hata H，Aoyagi S，Homma E，et al. Lymphangiosarcoma with strong positivity of D2-40 and LYVE-1 presenting different clinical features from angiosarcoma. J Dermatol，2014，41（7）:656-657. [8] Rudno-Rudzinska J，Kielan W，Grzebieniak Z，et al. High density of peritumoral lymphatic vessels measured by D2-40/podoplanin and LYVE-1 expression in gastric cancer patients: an excellent prognostic indicator or a false friend? Gastric Cancer，2013，16（4）:513-520. [9] Heinzelbecker J，Kempf KM，Kurz K，et al. Lymph vessel density in seminomatous testicular cancer assessed with the specific lymphatic endothelium cell markers D2-40 and LYVE-1:correlation with pathologic parameters and clinical outcome. Urol Oncol，2013，31（7）:1386-1394. [10] 柴红娟，施薇，杜光烨，等. D2-40在宫颈癌淋巴管生成、淋巴管浸润中的临床意义. 实用医学杂志，2014，30（12）:2019-2020. [11] Rakocevic J，Kojic S，Orlic D，et al. Co-expression of vascular and lymphatic endothelial cell markers on early endothelial cells present in aspirated coronary thrombi from patients with ST-elevation myocardial infarction. Exp Mol Pathol，2016，100（1）:31-38. [12] O TM，Lou MS，Ma Y. Zinc effect on human lymphatic malformation cells in vitro. Int J Pediatr Otorhinolaryngol，2016，80（5）:33-38. [13] Yang X，Zhai N，Sun M，et al. Influence of lymphatic endothelial cells on proliferation and invasiveness of esophageal carcinoma cells in vitro and lymphangiogenesis in vivo. Med Oncol，2015，32（8）:222-228. [14] Li XP，Jing W，Sun JJ，et al. A potential small-molecule synthetic antilymphangiogenic agent norcantharidin inhibits tumor growth and lymphangiogenesis of human colonic adenocarcinomas through blocking VEGF-A，-C，-D/VEGFR-2，-3“multi-points priming” mechanisms in vitro and in vivo. BMC Cancer，2015，15（2）:527-531. [15] Koina ME，Baxter L，Adamson SJ，et al. Evidence for lymphatics in the developing and adult human choroid. Invest Ophthalmol Vis Sci，2015，56（2）:1310-1327.
